AAAAAA

   
Results: 1-7 |
Results: 7
Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes - Prospective analysis from PURSUIT
Authors: Tardiff, BE Jennings, LK Harrington, RA Gretler, D Potthoff, RF Vorchheimer, DA Eisenberg, PR Lincoff, AM Labinaz, M Joseph, DM McDougal, MF Kleiman, NS
Citation: Be. Tardiff et al., Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes - Prospective analysis from PURSUIT, CIRCULATION, 104(4), 2001, pp. 399-405
A dose-determining trial of heparinase-I (Neutralase (TM)) for heparin neutralization in coronary artery surgery
Authors: Heres, EK Horrow, JC Gravlee, GP Tardiff, BE Luber, J Schneider, J Barragry, T Broughton, R
Citation: Ek. Heres et al., A dose-determining trial of heparinase-I (Neutralase (TM)) for heparin neutralization in coronary artery surgery, ANESTH ANAL, 93(6), 2001, pp. 1446-1452
Effect of eptifibatide on angiographic complications during percutaneous coronary intervention in the IMPACT-(Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis) II trial
Authors: Blankenship, JC Sigmon, KN Pieper, KS O'Shea, C Tardiff, BE Tcheng, JE
Citation: Jc. Blankenship et al., Effect of eptifibatide on angiographic complications during percutaneous coronary intervention in the IMPACT-(Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis) II trial, AM J CARD, 88(9), 2001, pp. 969-973
Evaluating the potential 'economic attractiveness' of new therapies in patients with non-ST elevation acute coronary syndrome
Authors: Eisenstein, EL Peterson, ED Jollis, JG Tardiff, BE Califf, RM Knight, JD Mark, DB
Citation: El. Eisenstein et al., Evaluating the potential 'economic attractiveness' of new therapies in patients with non-ST elevation acute coronary syndrome, PHARMACOECO, 17(3), 2000, pp. 263-272
Immediate coronary artery bypass surgery after platelet inhibition with eptifibatide: Results from PURSUIT
Authors: Dyke, CM Bhatia, D Lorenz, TJ Marso, SP Tardiff, BE Hogeboom, C Harrington, RA
Citation: Cm. Dyke et al., Immediate coronary artery bypass surgery after platelet inhibition with eptifibatide: Results from PURSUIT, ANN THORAC, 70(3), 2000, pp. 866-871
Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II)
Authors: Thel, MC Califf, RM Tardiff, BE Gardner, LH Sigmon, KN Lincoff, AM Topol, EJ Kitt, MM Blankenship, JC Tcheng, JE
Citation: Mc. Thel et al., Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II), AM J CARD, 85(4), 2000, pp. 427-434
Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention
Authors: Tardiff, BE Califf, RM Tcheng, JE Lincoff, AM Sigmon, KN Harrington, RA Mahaffey, KW Ohman, EM Teirstein, PS Blankenship, JC Kitt, MM Topol, EJ
Citation: Be. Tardiff et al., Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention, J AM COL C, 33(1), 1999, pp. 88-96
Risultati: 1-7 |